Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-K/A
Source: 0001731122-25-000252
Chunk: 116

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-K/A
Chunk 116
---
2024 and 2023  | F-7  |
| Consolidated Statement of Stockholders’ Equity for the Years Ended June 30, 2024 and 2023 | F-8  |
| Consolidated Statements of Cash Flows for the Years Ended June 30, 2024 and 2023          | F-9  |
| Notes to the Consolidated Financial Statements                                            | F-10 |

<div align='center'>F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

To the Board of Directors and Shareholders of Renovaro,
Inc.:

Opinion on the Financial Statements

We have audited the accompanying consolidated balance
sheets of Renovaro, Inc. (“the Company”) as of June 30, 2024 and 2023, the related consolidated statements of operations,
comprehensive loss, stockholders’ equity, and cash flows for each of the years in the two-year period ended June 30, 2024 and the
related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements referred
to above present fairly, in all material respects, the financial position of the Company as of June 30, 2024 and 2023, and the results
of its operations and its cash flows for each of the years in the two-year period ended June 30, 2024, in conformity with accounting principles
generally accepted in the United States of America.

Restatement of Financial Statements

As discussed in Note 2 to the financial statements,
the financial statements as of and for the year ended June 30, 2024 have been restated to correct misstatements.

Explanatory Paragraph Regarding Going Concern

The accompanying financial statements have been prepared
assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company has incurred
substantial recurring losses from operations, has used cash in the Company’s continuing operations, and is dependent on additional
financing to fund operations which raises substantial doubt about its ability to continue as a going concern. Management's plans in regard
to these matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome
of this uncertainty.

Basis for Opinion

These financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our
audits. We are a